H. Oberbauer

1.5k total citations
17 papers, 1.1k citations indexed

About

H. Oberbauer is a scholar working on Psychiatry and Mental health, Neurology and Physiology. According to data from OpenAlex, H. Oberbauer has authored 17 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Psychiatry and Mental health, 8 papers in Neurology and 4 papers in Physiology. Recurrent topics in H. Oberbauer's work include Schizophrenia research and treatment (9 papers), Alcoholism and Thiamine Deficiency (4 papers) and Epilepsy research and treatment (4 papers). H. Oberbauer is often cited by papers focused on Schizophrenia research and treatment (9 papers), Alcoholism and Thiamine Deficiency (4 papers) and Epilepsy research and treatment (4 papers). H. Oberbauer collaborates with scholars based in Austria, United States and Germany. H. Oberbauer's co-authors include Martina Hummer, Martin Kurz, Georg Kemmler, Anne Whitworth, W. Wolfgang Fleischhacker, I. Kurzthaler, Hartmann Hinterhuber, Josef Marksteiner, W. W. Fleischhacker and Christian Humpel and has published in prestigious journals such as The Lancet, American Journal of Psychiatry and Psychopharmacology.

In The Last Decade

H. Oberbauer

15 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
H. Oberbauer Austria 14 457 287 266 207 181 17 1.1k
B. Szelies Germany 22 445 1.0× 386 1.3× 263 1.0× 224 1.1× 177 1.0× 54 1.4k
Eric B. Larson United States 16 288 0.6× 463 1.6× 297 1.1× 95 0.5× 235 1.3× 23 1.1k
S. Engelborghs Belgium 16 254 0.6× 375 1.3× 223 0.8× 144 0.7× 108 0.6× 26 1.0k
Brendan Kelley United States 16 302 0.7× 244 0.9× 192 0.7× 103 0.5× 81 0.4× 33 973
Kenji Wada‐Isoe Japan 20 272 0.6× 271 0.9× 409 1.5× 128 0.6× 66 0.4× 44 1.2k
Chun-Hsin Chen Taiwan 24 430 0.9× 245 0.9× 110 0.4× 101 0.5× 105 0.6× 53 1.3k
S. Mazza Italy 18 311 0.7× 157 0.5× 169 0.6× 128 0.6× 47 0.3× 38 971
N. P. L. G. Verhoeff Netherlands 18 524 1.1× 411 1.4× 208 0.8× 367 1.8× 55 0.3× 38 1.4k
Birgitta Näsman Sweden 17 141 0.3× 325 1.1× 86 0.3× 117 0.6× 101 0.6× 22 1.1k
Soichiro Shimizu Japan 23 567 1.2× 560 2.0× 328 1.2× 81 0.4× 80 0.4× 86 1.4k

Countries citing papers authored by H. Oberbauer

Since Specialization
Citations

This map shows the geographic impact of H. Oberbauer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Oberbauer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Oberbauer more than expected).

Fields of papers citing papers by H. Oberbauer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. Oberbauer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Oberbauer. The network helps show where H. Oberbauer may publish in the future.

Co-authorship network of co-authors of H. Oberbauer

This figure shows the co-authorship network connecting the top 25 collaborators of H. Oberbauer. A scholar is included among the top collaborators of H. Oberbauer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. Oberbauer. H. Oberbauer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Marksteiner, Josef, Georg Kemmler, Elisabeth M. Weiss, et al.. (2009). Five out of 16 plasma signaling proteins are enhanced in plasma of patients with mild cognitive impairment and Alzheimer's disease. Neurobiology of Aging. 32(3). 539–540. 125 indexed citations
2.
Marksteiner, Josef, Michael Pirchl, Celine Ullrich, et al.. (2008). Analysis of Cerebrospinal Fluid of Alzheimer Patients. Pharmacology. 82(3). 214–220. 21 indexed citations
3.
Blasko, Imrich, Wolfgang Lederer, H. Oberbauer, et al.. (2005). Measurement of Thirteen Biological Markers in CSF of Patients with Alzheimer’s Disease and Other Dementias. Dementia and Geriatric Cognitive Disorders. 21(1). 9–15. 137 indexed citations
4.
Hummer, Martina, Georg Kemmler, Martin Kurz, et al.. (1999). Sexual Disturbances During Clozapine and Haloperidol Treatment for Schizophrenia. American Journal of Psychiatry. 156(4). 631–633. 98 indexed citations
5.
Miller, Carl H., et al.. (1997). Risk factors for the development of neuroleptic induced akathisia. European Neuropsychopharmacology. 7(1). 51–55. 28 indexed citations
6.
Hummer, Martina, et al.. (1997). Hepatotoxicity of Clozapine. Journal of Clinical Psychopharmacology. 17(4). 314–317. 86 indexed citations
7.
Hummer, Martina, Barbara Sperner‐Unterweger, Martin Kurz, et al.. (1996). Does eosinophilia predict clozapine induced neutropenia?. Psychopharmacology. 124(1-2). 201–204. 23 indexed citations
8.
Whitworth, Anne, H. Oberbauer, WW Fleischhacker, et al.. (1996). Comparison of acamprosate and placebo in long-term treatment of alcohol dependence. The Lancet. 347(9013). 1438–1442. 234 indexed citations
9.
Kurz, Martin, Martina Hummer, H. Oberbauer, I. Kurzthaler, & W. Wolfgang Fleischhacker. (1996). Termination of clozapine treatment. Schizophrenia Research. 18(2-3). 125–126. 1 indexed citations
10.
Hummer, Martina, et al.. (1996). Hepatotoxicity of clozapine. Schizophrenia Research. 18(2-3). 126–127. 9 indexed citations
11.
Oberbauer, H., J. Schwitzer, Christian Barnas, et al.. (1995). Tardive Dyskinesia Prevalence Rates During a Ten-Year Follow-Up. The Journal of Nervous and Mental Disease. 183(6). 404–407. 16 indexed citations
12.
Kurz, Martin, Martina Hummer, H. Oberbauer, & W. W. Fleischhacker. (1995). Extrapyramidal side effects of clozapine and haloperidol. Psychopharmacology. 118(1). 52–56. 69 indexed citations
13.
Hummer, Martina, et al.. (1995). Weight gain induced by clozapine. European Neuropsychopharmacology. 5(4). 437–440. 93 indexed citations
14.
15.
Stuppaeck, C., Roger Pycha, C. Miller, et al.. (1992). Carbamazepine versus oxazepam in the treatment of alcohol withdrawal: a double-blind study.. PubMed. 27(2). 153–8. 95 indexed citations
16.
Hummer, Martina, C. Barnas, Martin Kurz, H. Oberbauer, & W. Wolfgang Fleischhacker. (1992). Hematologic side effects of clozapine. European Neuropsychopharmacology. 2(3). 351–352.
17.
Stuppaeck, C., Roger Pycha, C. Miller, et al.. (1992). CARBAMAZEPINE VERSUS OXAZEPAM IN THE TREATMENT OF ALCOHOL WITHDRAWAL: A DOUBLE-BLIND STUDY. Alcohol and Alcoholism. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by B. Szelies Breakdown of academic impact, for papers by Eric B. Larson Breakdown of academic impact, for papers by S. Engelborghs Breakdown of academic impact, for papers by Brendan Kelley Breakdown of academic impact, for papers by Kenji Wada‐Isoe Breakdown of academic impact, for papers by Chun-Hsin Chen Breakdown of academic impact, for papers by S. Mazza Breakdown of academic impact, for papers by N. P. L. G. Verhoeff Breakdown of academic impact, for papers by Birgitta Näsman Breakdown of academic impact, for papers by Soichiro Shimizu
Rankless by CCL
2026